To hear about similar clinical trials, please enter your email below
Trial Title:
Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
NCT ID:
NCT05587972
Condition:
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Multiple Myeloma
Conditions: Official terms:
Multiple Myeloma
Neoplasms, Plasma Cell
Gastrointestinal Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
survey
Description:
Patients will complete a baseline survey in person using a secured device or remotely
using their own electronic device in a location of their choice. Weekly electronic PRO
surveys are collected from the patients using the Carevive platform for a minimum of 12
weeks.
Summary:
The Carevive registry collects patient characteristics, patient symptoms, and treatment
experience data from patients receiving cancer treatment for breast, lung, GI or multiple
myeloma. For this study, a core set of variables is collected on each patient in the
Carevive platform. Patients will complete a baseline survey in person using a secured
device or remotely using their own electronic device in a location of their choice.
Weekly electronic Patient Reported Outcome surveys are collected from the patients using
the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as
long as they are receiving treatment.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- All participants must be 18 years of age or older.
- Subjects may be any stage and anywhere in the treatment continuum.
- Subject participants must have a diagnosis of breast, lung, GI or ovarian cancer or
multiple myeloma.
- Subjects must be able to complete on-line surveys using a cell phone, tablet, or
computer.
- All participants must be able to understand English.
Exclusion Criteria:
- Any patient who cannot understand written or spoken English.
- Any patient without the ability to complete on-line surveys using a cell phone,
tablet, or computer.
- Any patient on a treatment clinical trial.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart
B, C and D).
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Cleveland Clinic
Address:
City:
Cleveland
Zip:
44131
Country:
United States
Start date:
October 6, 2022
Completion date:
December 6, 2024
Lead sponsor:
Agency:
Carevive Systems, Inc.
Agency class:
Industry
Source:
Carevive Systems, Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05587972
